NDAORALCAPSULE
Approved
Jun 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
10
Clinical Trials (5)
Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis
Started Jan 2017
21 enrolled
Secondary Hyperparathyroidism-Chronic Kidney Disease
Pilot Study Evaluating Doxercalciferol Replacement Therapy in Kidney Transplant Recipients
Started Nov 2008
39 enrolled
Chronic Kidney DiseaseKidney Transplantation
Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)
Started Nov 2008
24 enrolled
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis
Started Apr 2008
111 enrolled
Moderate to Severe Chronic Plaque Psoriasis
A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection
Started Apr 2007
36 enrolled
Secondary Hyperparathyroidism